# Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours

> **NCT03770234** · PHASE1 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 30 (actual)

## Conditions studied

- Pain
- Pharmacokinetics

## Interventions

- **DRUG:** Transtec 35 µg/hour transdermal patch

## Key facts

- **NCT ID:** NCT03770234
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-05
- **Primary completion:** 2004-05-26
- **Final completion:** 2004-05-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770234, "Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03770234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*